Hyperhomocysteinemia and immune activation

Clinical Chemistry and Laboratory Medicine

Volumn 41, Issue 11, 2003, Pages 1438-1443

  Schroecksnadel, Katharina ^a   Frick, Barbara ^a   Winkler, Christiana ^a,b   Leblhuber, Friedrich ^c   Wirleitner, Barbara ^a   Fuchs, Dietmar ^a,b  

^a UNIVERSITY OF INNSBRUCK   (Austria)

^b LUDWIG BOLTZMANN INSTITUTE FOR LUNG VASCULAR RESEARCH   (Austria)

^c Landesnervenklinik Wagner Jauregg ^*  (Austria)

Author keywords

Homocysteine; Immune activation; Immunopathogenesis; Neopterin; Oxidative stress

Indexed keywords

ANTIOXIDANT; FOLIC ACID; HOMOCYSTEINE; NEOPTERIN; PEROXIDE; REACTIVE OXYGEN METABOLITE;

AMINO ACID BLOOD LEVEL; AMINO ACID METABOLISM; ATHEROGENESIS; ATHEROSCLEROSIS; CELL PROLIFERATION; CONCENTRATION (PARAMETERS); DEMENTIA; DISEASE ASSOCIATION; HUMAN; HYPERHOMOCYSTEINEMIA; IMMUNE SYSTEM; IMMUNOCOMPETENT CELL; IN VITRO STUDY; IN VIVO STUDY; ISCHEMIC HEART DISEASE; PRIORITY JOURNAL; REVIEW; RHEUMATOID ARTHRITIS; T LYMPHOCYTE ACTIVATION; TH1 CELL;

CYTOKINES; DEMENTIA; HOMOCYSTEINE; HUMANS; HYPERHOMOCYSTEINEMIA; REACTIVE OXYGEN SPECIES; VASCULAR DISEASES;

EID: 0344306699     PISSN: 14346621     EISSN: None     Source Type: Journal    
DOI: 10.1515/CCLM.2003.221     Document Type: Review

References (40)

1. Boushey CJ, Beresford SA, Omenn GS, Motulsky AG. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes. J Am Med Assoc 1995; 274:1049-57.
2. Herrmann W. The importance of hyperhomocysteinemia as a risk factor for diseases: an overview. Clin Chem Lab Med 2001; 39:666-74.
3. Pettersson T, Friman C, Abrahamsson L, Nilsson B, Norberg B. Serum homocysteine and methylmalonic acid in patients with rheumatoid arthritis and cobalaminopenia. J Rheumatol 1998; 25:859-63.
4. McIlroy SP, Dynan KB, Lawson JT, Patterson CC, Passmore AP. Moderately elevated plasma homocysteine, methylenetetrahydrofolate reductase genotype, and risk for stroke, vascular dementia, and Alzheimer disease in Northern Ireland. Stroke 2002; 33:2351-6.
5. Almadori G, Bussu F, Galli J, Cadoni G, Zappacosta B, Persichilli S, et al. Serum folate and homocysteine levels in head and neck squamous cell carcinoma. Cancer 2002; 94:1006-11.
6. Lentz SR, Erger RA, Dayal S, Maeda N, Malinow MR, Heistad DD, et al. Folate dependence of hyperhomocysteinemia and vascular dysfunction in cystathionine beta-synthase-deficient mice. Am J Physiol Heart Circ Physiol 2000; 279:H970-H5.
7. 6 and one carbon metabolism. J Nutr Health Aging 2002; 6:39-42.
8. Eikelboom JW, Lonn E, Genest J, Hankey G, Yusuf S. Homocyst(e)ine and cardiovascular disease: a critical review of the epidemiologic evidence. Ann Int Med 1999; 131:363-75.
9. Schroecksnadel K, Leblhuber F, Frick B, Gruber B, Wirleitner B, Schennach H, et al. Hyperhomocysteinemia in Alzheimer's disease coincides with immune activation. In: Proceedings of 15th European Congress of Clinical Chemistry and Laboratory Medicine, EUROMEDLAB 2003, Barcelona, June 1-5, 2003, Bologna: Monduzzi Editore SW. p. A. MEDIMOND Inc. 2003:857-60.
10. Dudman NP, Hicks C, Wang J, Wilcken DE. Human arterial endothelial cell detachment in vitro: its promotion by homocysteine and cysteine. Atherosclerosis 1991; 91:77-83.
11. Wall RT, Harlan JM, Harker LA, Striker GE. Homocysteine-induced endothelial cell injury in vitro: a model for the study of vascular injury. Thromb Res 1980; 18:113-21.
12. Chambers JC, McGregor A, Jean-Marie J, Obeid OA, Kooner JS. Demonstration of rapid onset vascular endothelial dysfunction after hyperhomocysteinemia: an effect reversible with vitamin C therapy. Circulation 1999; 99:1156-60.
13. Ungvari Z, Pacher P, Rischak K, Szollar L, Koller A. Dysfunction of nitric oxide mediation in isolated rat arterioles with methionine diet-induced hyperhomocysteinemia. Arterioscler Thromb Vasc Biol 1999; 19:1899-904.
14. Jacobsen DW. Cardiovascular disorders (risk assessment). Anal Chem 1993; 65:367R-73R.
15. Erren M, Reinecke H, Junker R, Fobker M, Schulte H, Schurek JO, et al. Systemic inflammatory parameters in patients with atherosclerosis of the coronary and peripheral arteries. Arterioscler Thromb Vasc Biol 1999; 19:2355-6.
16. Rogers J, Webster S, Lue LF, Brachova L, Civin WH, Emmerling M, et al. Inflammation and Alzheimer's disease pathogenesis. Neurobiol Aging 1996; 17:681-6.
17. Fuchs D, Jaeger M, Widner B, Wirleitner B, Artner-Dworzak E, Leblhuber F. Is hyperhomocysteinemia due to the oxidative depletion of folate rather than to insufficient dietary intake? Clin Chem Lab Med 2001; 39:691-4.
18. Refsum H, Wesenberg F, Ueland PM. Plasma homocysteine in children with acute lymphoblastic leukemia: changes during a chemotherapeutic regimen including methotrexate. Cancer Res 1991; 51:828-35.
19. Schroecksnadel K, Frick B, Wirleitner B, Schennach H, Fuchs D. Homocysteine accumulates in supernatants of stimulated human peripheral blood mononuclear cells. Clin Exp Immunol 2003; 134:53-6.
20. Owen AD, Schapira AH, Jenner P, Marsden CD. Indices of oxidative stress in Parkinson's disease, Alzheimer's disease and dementia with Lewy bodies. J Neural Transm Suppl 1997; 51:167-73.
21. Bashir S, Harris G, Denman MA, Blake DR, Winyard PG. Oxidative DNA damage and cellular sensitivity to oxidative stress in human autoimmune diseases. Ann Rheum Dis 1993; 52:659-66.
22. Frick B, Rudzite V, Schröcksnadel K, Kalnins U, Erglis A, Trusinskis K, et al. Coincidental increase of homocysteine and neopterin in patients with coronary heart disease. Pteridines 2003; 14:43.
23. Widner B, Leblhuber F, Frick B, Laich A, Artner-Dworzak E, Fuchs D. Moderate hyperhomocysteinaemia and immune activation in Parkinson's disease. J Neural Transm 2002; 109:1445-52.
24. Schroecksnadel K, Frick B, Neurauter G, Kaser S, Wirleitner B, Ledochowski M, et al. Hyperhomocysteinemia and immune activation in patients with rheumatoid arthritis. Clin Chim Acta. In press.
25. Murr C, Fuith LC, Widner B, Wirleitner B, Baier-Bitterlich G, Fuchs D. Increased neopterin concentrations in patients with cancer: indicator of oxidative stress? Anticancer Res 1999; 19:1721-8.
26. Leblhuber F, Walli J, Artner-Dworzak E, Vrecko K, Widner B, Reibnegger G, et al. Hyperhomocysteinemia in dementia. J Neural Transm 2000; 107:1469-74.
27. Frick B, Neurauter G, Diez-Ruiz A, Schroecksnadel K, Wirleitner B, Leblhuber F, et al. Neopterin a y productos oxidativos en sagre de pacientos con varias formas de demencia. Investig Clin [Spanish] 2003; 5:110-4.
28. Witko-Sarsat V, Friedlander M, Nguyen Khoa T, Capeillere-Blandin C, Nguyen AT, Canteloup S, et al. Advanced oxidation protein products as novel mediators of inflammation and monocyte activation in chronic renal failure. J Immunol 1998; 161:2524-32.
29. Sattler W, Leblhuber F, Walli J, Widner B, Fuchs D. Cerebrospinal fluid levels of α-tocopherol and neopterin in patients with dementia. Pteridines 1999; 10:220-4.
30. Solichova D, Melichar B, Svoboda I, Blaha V, Zadak Z. Fluorescence analysis of antioxidant vitamins and neopterin in nonagenarians. Biomed Chromatogr 1999; 13:117-8.
31. Hronek M, Zadak Z, Solichova D, Jandik P, Melichar B. The association between specific nutritional antioxidants and manifestation of colorectal cancer. Nutrition 2000; 16:189-91.
32. Widner B, Enzinger C, Laich A, Wirleitner B, Fuchs D. Hyperhomocysteinemia, pteridines and oxidative stress. Current Drug Metabol 2002; 3:225-32.
33. Fuchs D, Weiss G, Reibnegger G, Wachter H. The role of neopterin as a monitor of cellular immune activation in transplantation, inflammatory, infectious and malignant diseases. Crit Rev Clin Lab Sci 1992; 29:307-41.
34. McCaddon A, Regland B, Hudson P, Davies G. Functional vitamin B(12) deficiency and Alzheimer disease. Neurology 2002; 58:1395-9.
35. Kiechl S, Lorenz E, Reindl M, Wiedermann CJ, Oberhollenzer F, Bonora E, et al. Toll-like receptor 4 polymorphisms and atherogenesis. N Engl J Med 2002; 347:185-92.
36. Kalayoglu MV, Libby P, Byrne GI. Chlamydia pneumoniae as an emerging risk factor in cardiovascular disease. J Am Med Assoc 2002; 288:2724-31.
37. O'Callaghan P, Meleady R, Fitzgerald T, Graham I. European COMAC group. Smoking and plasma homocysteine. Eur Heart J 2002; 23:1580-6.
38. Schennach H, Murr C, Gächter E, Mayersbach P, Schönitzer D, Fuchs D. Factors influencing serum neopterin concentrations in a population of blood donors. Clin Chem 2002; 48:643-5.
39. Wang H, Yu M, Ochani M, Amella CA, Tanovic M, Susarla S, et al. Nicotinic acetylcholine receptor alpha7 subunit is an essential regulator of inflammation. Nature 2003; 421: 384-8.
40. Obeid R, Geisel J, Schorr H, Hubner U, Herrmann W. The impact of vegetarianism on some haematological parameters. Eur J Haematol 2002;69: 275-9.